Beranda › Eksim › New York › New York City
Uji klinis Eksim di New York City, NY
5 studi untuk Eksim mencari peserta di lokasi sekitar New York City (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis
Menerima peserta
- Weill Cornell Medicine, New York
- Columbia University Irving Medical Center, New York
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
Menerima pesertaFase 2
- Sadick Research Group, LLC, New York
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
Menerima pesertaFase 2
- Inmagene Site 21, New York
Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)
Menerima pesertaFase 1
- Icahn School of Medicine at Mount Sinai: Department of Pediatrics Allergy & Immunology, New York
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
Menerima pesertaFase 2
- Private Practice - Dr. Bobby Buka, New York
- Icahn School of Medicine at Mount Sinai, New York
- Sadick Research Group, New York
Uji klinis Eksim di kota lain
- San Antonio, TX7 studi
- Birmingham, AL6 studi
- Los Angeles, CA5 studi
- San Diego, CA5 studi
- Indianapolis, IN5 studi
- Washington, DC4 studi
- Huntington Beach, CA4 studi
- Miami, FL4 studi
- Santa Clarita, CA4 studi
- Pittsburgh, PA4 studi
- Phoenix, AZ4 studi
- San Francisco, CA3 studi
Studi lain di New York City
- Kanker Payudara136 studi
- Kanker Paru Non-Sel Kecil121 studi
- Kanker (semua jenis)109 studi
- Kanker Prostat103 studi
- Kanker Metastatik93 studi
- Kanker Kolorektal78 studi
- Kanker Ovarium69 studi
- Kanker Paru60 studi
- Mieloma Multipel60 studi
- Kanker Pankreas60 studi
- Kanker Endometrium52 studi
- Leukemia Mieloid Akut51 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.